Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocular Therapeutix Inc (NASDAQ:OCUL)

17.59
Delayed Data
As of Sep 02
 +0.73 / +4.33%
Today’s Change
13.00
Today|||52-Week Range
44.19
-25.21%
Year-to-Date
No recent news for Ocular Therapeutix Inc.

Today’s Trading

Previous close16.86
Today’s open17.05
Day’s range16.60 - 17.61
Volume152,239
Average volume (3 months)297,273
Market cap$416.8M
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-668.57%
Earnings growth (this year)+43.77%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales324.55
Price/Book6.13

Competitors

 Today’s
change
Today’s
% change
CVRSCorindus Vascular Ro...-0.09-2.62%
BLCMBellicum Pharmaceuti...+0.41+2.49%
GIEndoChoice Holdings ...+0.07+0.44%
BEATBioTelemetry Inc+0.96+6.66%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$772.0K
Annual profit (last year)-$28.6M
Net profit margin-3,710.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Amarpreet S. Sawhney
Chief Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts

Partner Offers